RxDoctor Payments Data

William Yoder, DPM

Foot & Ankle Surgery · Kenosha, WINPI 1770819567

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (59.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Arthrex at 33.2% of the total. Reporting peaked in 2019 at $2,334 and has fallen 72.7% since, to $637 in 2025.

$4,162in general payments, 2019–2025

Across 90 payments — averaging $46.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$1K
  • Great Lakes Orthopedics$478
  • Smith+Nephew$454
  • ANI Pharmaceuticals, Inc.$297
  • Integra Lifesciences Corporation$241
  • Paratek Pharmaceuticals, Inc.$129
  • plus $1K from 24 others

What the payments were for

  • Travel & lodging$3859%
  • Food & beverage$2,47960%
  • Education$1,29931%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,162 in reported general payments places this provider in the 60th percentile of 105 foot & ankle surgery providers in Wisconsin.

See all foot & ankle surgery providers in Wisconsin

Medicare billing

Part B allowed, 2024
$240,818
Medicare patients
575
Services billed
10,231

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MupirocinMupirocin Calcium203$43,304
Calcipotriene92$25,647
Naftifine Hcl85$14,540
Ciclopirox171$8,045
Lidocaine48$4,777
Diclofenac Sodium91$4,495
Ketoconazole90$3,954
Tobramycin-DexamethasoneTobramycin/Dexamethasone30$2,614
Triamcinolone Acetonide45$2,285
Diclofenac Sodium ErDiclofenac Sodium25$1,505
Nystatin45$1,174
Ammonium Lactate30$590
Clobetasol Propionate15$457
Mupirocin14$364
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$298

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Kenosha

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →